Literature DB >> 8790167

Diagnosis of palpable breast lesions in younger women by the modified triple test is accurate and cost-effective.

J T Vetto1, R F Pommier, W A Schmidt, H Eppich, P W Alexander.   

Abstract

OBJECTIVE: To study the accuracy and cost of diagnosing palpable breast lesions in younger patients using a modified triple test (MTT: physical examination, ultrasonography instead of mammography, and fine-needle aspiration).
DESIGN: Diagnostic test study and cost-effectiveness estimate.
SETTING: Multidisciplinary university breast clinic. PATIENTS: Fifty-five women below the recommended age of screening mammography (mean age, 33 years) with unilateral, palpable breast lesions. INTERVENTION: Each lesion was tested by all 3 elements of MTT, and each element was interpreted as benign, suspicious, or malignant. MAIN OUTCOME MEASURES: Patients with MTTs in which all elements were concordant (in agreement) and benign were evaluated clinically (mean follow-up, 11 months). Patients in whom the results of fine-needle aspiration were scored as suspicious or malignant underwent open confirmatory biopsy.
RESULTS: Forty-eight patients had concordant benign MTTs, including 14 patients with breast cysts. No cancers developed at the index sites during follow-up, including 5 biopsies done at the patients' request (negative predictive value and specificity, 100%). Fine-needle aspiration and physical examination were more accurate than ultrasonography in the 7 cases in which MTT was nonconcordant. Compared with the criterion standard (physical examination and open biopsy), use of MTT under the conditions of this study could avoid open biopsies in almost all cases, with average savings in charges of up to $623 per case.
CONCLUSION: Use of MTT for the diagnosis of unilateral, palpable breast lesions in younger women yields high diagnostic accuracy without the need for routine open biopsy, resulting in an overall reduction in patient charges.

Entities:  

Mesh:

Year:  1996        PMID: 8790167     DOI: 10.1001/archsurg.1996.01430210065012

Source DB:  PubMed          Journal:  Arch Surg        ISSN: 0004-0010


  4 in total

1.  INVESTIGATION OF BREAST LUMPS: AN EVALUATION.

Authors:  A Kumar; L S Vohra; S Bhargava; P S Reddy
Journal:  Med J Armed Forces India       Date:  2017-06-26

2.  The Breast Health Global Initiative 2018 Global Summit on Improving Breast Healthcare Through Resource-Stratified Phased Implementation: Methods and overview.

Authors:  Catherine Duggan; Allison Dvaladze; Anne F Rositch; Ophira Ginsburg; Cheng-Har Yip; Susan Horton; Rolando Camacho Rodriguez; Alexandru Eniu; Miriam Mutebi; Jean-Marc Bourque; Shahla Masood; Karla Unger-Saldaña; Anna Cabanes; Robert W Carlson; Julie R Gralow; Benjamin O Anderson
Journal:  Cancer       Date:  2020-05-15       Impact factor: 6.860

Review 3.  Management of palpable breast lumps. Consensus guideline for family physicians.

Authors:  R Heisey; L Mahoney; B Watson
Journal:  Can Fam Physician       Date:  1999-08       Impact factor: 3.275

4.  Development of two ELISA for estrogen and progesterone receptor with sufficient sensitivity for fine needle aspirate and core biopsy.

Authors:  C F Sun; T L Wu; K C Tsao; J T Wu
Journal:  J Clin Lab Anal       Date:  2001       Impact factor: 2.352

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.